Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2/0 myeloma cells through affecting NFkappaB p65. (Q39804120)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2/0 myeloma cells through affecting NFkappaB p65.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2/0 myeloma cells through affecting NFkappaB p65. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

apoptotic process

0 references

0 references

author name string

Shihui Li

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Fang Xue

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Zhiyong Cheng

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Xiaoyang Yang

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Suyun Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Fengyong Geng

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Ling Pan

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

publication date

29 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

90

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

513-521

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-009-0409-Z

21 January 2018

The role of nuclear factor-kappaB in the biology and treatment of multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-kappaB-related survival pathway down-regulation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1)

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular modes of action of artesunate in tumor cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor cell "dead or alive": caspase and survivin regulate cell death, cell cycle and cell survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of Increasing Rates of Treatment Failure by Combining Sulfadoxine‐Pyrimethamine with Artesunate or Amodiaquine for the Sequential Treatment of Malaria

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The anti-malarial artesunate is also active against cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myeloma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel Therapies in Multiple Myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase 2 study of bortezomib in relapsed, refractory myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arsenic trioxide, a potent inhibitor of NF-kappaB, abrogates allergen-induced airway hyperresponsiveness and inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Artesunate combinations for treatment of malaria: meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

s-thalidomide has a greater effect on apoptosis than angiogenesis in a multiple myeloma cell line.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NF-kappa B as a therapeutic target in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19728025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-009-0409-Z

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39804120&oldid=2203186399"